Cleveland BioLabs (CBLI) Announces 8.81M Common in Private Offerings
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Join SI Premium – FREE
Cleveland BioLabs, Inc. (Nasdaq: CBLI) has entered into definitive purchase agreements with investors pursuant to which the Company agreed to sell an aggregate of approximately 5.873 million shares of its common stock and warrants exercisable for up to approximately 2.936 million additional shares of its common stock.
From the release: "The securities will be sold in units at a price of $4.00 per unit, with each unit consisting of one share of common stock, a Series E Warrant to purchase 0.25 shares of common stock and a Series F Warrant to purchase 0.25 shares of common stock. The Series E Warrants will be exercisable at a price of $4.50 per share beginning six months following the issuance date and will expire one year from the issuance date. The Series F Warrants will be exercisable at a price of $5.00 per share beginning six months following the issuance date and will expire five years from the issuance date. The closing of the offering is expected to take place on or about June 22, 2011, subject to the satisfaction of customary closing conditions."
The estimated net proceeds to the Company from the offering are expected to be approximately $22million.
From the release: "The securities will be sold in units at a price of $4.00 per unit, with each unit consisting of one share of common stock, a Series E Warrant to purchase 0.25 shares of common stock and a Series F Warrant to purchase 0.25 shares of common stock. The Series E Warrants will be exercisable at a price of $4.50 per share beginning six months following the issuance date and will expire one year from the issuance date. The Series F Warrants will be exercisable at a price of $5.00 per share beginning six months following the issuance date and will expire five years from the issuance date. The closing of the offering is expected to take place on or about June 22, 2011, subject to the satisfaction of customary closing conditions."
The estimated net proceeds to the Company from the offering are expected to be approximately $22million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
- Curvature Securities terminates ATM sales pact with Planet Green
- Nu Skin EVP of global sales takes medical leave
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
